Related Experiment Video
Updated: Dec 24, 2025
09:06
Microbioreactor-Based Production of Anchorage-Dependent Mesenchymal Stromal Cells Primed for Acute Respiratory Distress Syndrome
Published on: December 12, 2025
180
[New therapeutic strategies in ARDS]
S Gaudry1,2, D Dreyfuss1,2, J-D Ricard1,2
11Service de réanimation médicochirurgicale, hôpital Louis Mourier, 178 rue des Renouillers, F-92700 Colombes, France.
Summary
New findings in acute respiratory distress syndrome (ARDS) treatment show prone positioning and neuromuscular blocking agents improve survival. Extracorporeal membrane oxygenation (ECMO) and cell therapy show promise but require further clinical trials.
Area of Science:
- Critical care medicine
- Pulmonary medicine
- Respiratory physiology
Context:
- Acute respiratory distress syndrome (ARDS) presents complex treatment challenges with ongoing research and debate.
- Established and emerging therapies for ARDS have been evaluated for their impact on patient outcomes.
Purpose:
- To review recent findings on the efficacy of various treatments for acute respiratory distress syndrome.
- To assess the impact of interventions like prone positioning, neuromuscular blockers, ECMO, and cell therapy on ARDS prognosis.
Summary:
- Prone positioning improves survival in severe hypoxemic ARDS patients.
- Neuromuscular blocking agents administered early in ARDS enhance survival.
- Extracorporeal membrane oxygenation (ECMO) efficacy in ARDS requires further definition.
- Mesenchymal stem cell therapy shows potential for alveolar repair and infection prevention, pending clinical validation.
- Beta-2 adrenergic agonists and omega-3 fatty acids have demonstrated limitations in large ARDS clinical studies.
Impact:
- Revised understanding of ARDS management strategies, emphasizing survival benefits of specific interventions.
- Highlights the need for further clinical trials to validate novel therapies like cell therapy for ARDS.
- Informs clinical decision-making regarding the use of established and investigational treatments for ARDS patients.
Related Concept Videos
01:29Acute Respiratory Failure-V
372
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
372
01:22Heart Failure VI: Adjunct Therapies
184
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
184
01:17Drugs Used in Lower Respiratory Disorders: Overview
926
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
926
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
811
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
811
01:30Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques
370
Airway management is essential in emergency and surgical medicine, ensuring ventilation and oxygenation in patients who cannot maintain their own airway. Clinicians use a range of techniques and devices to secure the airway, depending on the patient’s condition and the clinical context. Key methods include endotracheal intubation, rapid sequence intubation (RSI), supraglottic airway devices, and advanced visualization aids. In cases where these approaches fail, surgical airway...
370
01:30Heart Failure V: Medical Management
159
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
159